FrancophonIA/ELRC3.0 huggingface dataset:
English: The recommended dose must be diluted in at least 100 ml of a compatible diluent and infused over 15-minutes.
Croatian: Preporučena doza mora biti razrijeđena u najmanje 100 ml kompatibilne otopine za razrjeđivanje i nakon toga primjenjena infuzijom kroz 15 minuta.
English: Talk to your doctor before taking Keppra
Croatian: Obratite se svom liječniku prije nego uzmete Keppru
English: Each ml contains 2.7 mg of methyl parahydroxybenzoate (E218), 0.3 mg of propyl parahydroxybenzoate (E216) and 300 mg of maltitol liquid.
Croatian: Jedan ml sadrži 2,7 mg metilparahidroksibenzoata (E218), 0,3 mg propilparahidroksibenzoata (E216) i 300 mg tekućeg maltitola.
English: What Keppra looks like and contents of the pack Keppra concentrate for solution for infusion (sterile concentrate) is a clear, colourless liquid.
Croatian: Keppra koncentrat za otopinu za infuziju (sterilni koncentrat) je bistra, bezbojna tekućina.
English: Keppra therapy can be initiated with either intravenous or oral administration.
Croatian: Liječenje Kepprom može se započeti intravenskom ili peroralnom primjenom.
English: Keppra 250 mg film-coated tablets Keppra 500 mg film-coated tablets Keppra 750 mg film-coated tablets Keppra 1000 mg film-coated tablets
Croatian: Keppra 250 mg filmom obložene tablete Keppra 500 mg filmom obložene tablete Keppra 750 mg filmom obložene tablete Keppra 1000 mg filmom obložene tablete levetiracetam
English: Keppra concentrate was found to be physically compatible and chemically stable when mixed with the following diluents for at least 24 hours and stored in PVC bags at controlled room temperature 1525°C.
Croatian: Utvrđeno je da je Keppra koncentrat fizikalno kompatibilan i kemijski stabilan kada se pomiješa sa sljedećim otopinama za razrjeđivanje tijekom barem 24 sata i ako se čuva u PVC vrećama pri kontroliranoj sobnoj temperaturi 15-25°C.
English: In both population pharmacokinetic analyses, there was about a 20 % increase of apparent clearance of levetiracetam when it was co-administered with an enzyme-inducing antiepileptic medicinal product.
Croatian: U obje farmakokinetičke analize populacije prividni klirens levetiracetama se povećao za oko 20 % kada se lijek davao istodobno s antiepileptikom koji inducira enzime.
English: Insert the adaptor into the bottle neck (figure 3).
Croatian: Utisnite nastavak za štrcaljku na vrat boce (slika 3).
English: Dose and frequency (1) Infants 1 to less than 6 months
Croatian: Doza i učestalost primjene (1) Dojenčad od 1 do manje od 6 mjeseci
English: UCB Pharma SA, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium or
Croatian: UCB Pharma SA, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgija ili
English: Dose recommendations for infants from 6 months of age, children and adolescents: Weight
Croatian: Preporučene doze za dojenčad od 6. mjeseca života, djecu i adolescente: Tjelesna težina
English: Multipack: 200 (2 packs of 100) film-coated tablets
Croatian: OBLIK I SADRŽAJ Višestruko pakiranje: 200 (2 pakiranja od 100) filmom obloženih tableta
English: • Sodium chloride 9 mg/ml (0.9%) solution for injection
Croatian: • otopina natrijeva klorida 9 mg/ml (0,9 %) za injekciju
English: Dose in children 6 months and older: Weight
Croatian: Doza u djece u dobi od 6 mjeseci i starije: Tjelesna težina
English: Your doctor will prescribe the most appropriate pharmaceutical form of Keppra according to the age, weight and dose.
Croatian: Liječnik će propisati najprikladniji farmaceutski oblik Keppre sukladno dobi, tjelesnoj težini i dozi.
English: Do not take Keppra
Croatian: Nemojte uzimati Keppru
English: In a study reflecting clinical practice, the concomitant antiepileptic medication could be withdrawn in a limited number of patients who responded to levetiracetam adjunctive therapy (36 adult patients out of 69).
Croatian: U studiji koja je bila odraz kliničke prakse, bilo je moguće prekinuti istodobno antiepileptičko liječenje u ograničenog broja bolesnika koji su odgovorili na dodatno liječenje levetiracetamom (36 od 69 odraslih bolesnika).
English: UCB Pharma SA, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium.
Croatian: UCB Pharma SA, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgija.
English: How Keppra is given
Croatian: Kako se Keppra daje
English: Paediatric population The tablet formulation is not adapted for use in infants and children under the age of 6 years.
Croatian: Pedijatrijska populacija Farmaceutski oblik tableta nije prilagođen za primjenu u dojenčadi i djece mlađe od 6 godina.
English: Keppra concentrate for solution for infusion was found to be physically compatible and chemically stable for at least 24 hours when mixed with the following diluents and stored in PVC bags at controlled room temperature 15-25 °C.
Croatian: Utvrđeno je da je Keppra koncentrat za otopinu za infuziju fizikalno kompatibilan i kemijski stabilan tijekom barem 24 sata kada se pomiješa sa sljedećim otopinama za razrjeđivanje i ako se čuva u PVC vrećama pri kontroliranoj sobnoj temperaturi od 15-25°C.
English: Infants should start the treatment with Keppra 100 mg/ml oral solution.
Croatian: Dojenčad treba započeti liječenje sa Keppra 100 mg/ml oralnom otopinom.
English: If stopping treatment, Keppra should be discontinued gradually to avoid an increase of seizures.
Croatian: Ako prekidate liječenje Kepprom, prekid mora biti postupan kako bi se izbjeglo pojačanje napadaja.
English: Results related to behavioural and emotional functioning indicated a worsening in levetiracetamtreated patients on aggressive behaviour as measured in a standardised and systematic way using a validated instrument (CBCL - Achenbach Child Behavior Checklist).
Croatian: Rezultati ocjene funkcioniranja ponašanja i emocionalnog funkcioniranja uputili su na pogoršanje u smislu agresivnijeg ponašanja u skupini koja je uzimala levetiracetam, ocijenjenog na standardiziran i sistematičan način koristeći validiran instrument (CBCL - Achenbach Child Behavior Checklist) na standardiziran i sistematičan način.
English: Peak concentrations (Cmax) are typically 31 and 43 µg/ml following a single 1,000 mg dose and repeated 1,000 mg twice daily dose, respectively.
Croatian: Vršna koncentracija (Cmax) uglavnom je 31 μg/ml nakon jedne doze od 1,000 mg i 43 μg/ml nakon ponovljene doze od 1,000 mg dva puta na dan.
English: • There is no experience with administration of intravenous levetiracetam for a longer period than 4 days.
Croatian: Nema iskustva s levetiracetamom primijenjenim intravenski u razdoblju duljem od 4 dana.
English: General dose: Keppra is taken twice daily, in two equally divided doses, each individual dose being measured between 0.1 ml (10mg) and 0.3 ml (30mg), per kg bodyweight of the child. (see table below for dose examples).
Croatian: Uobičajena doza: Keppra se uzima dva puta na dan, u dvije jednako podijeljene doze, a svaku pojedinu dozu treba odmjeriti između 0,1 ml (10 mg) i 0,3 ml (30 mg), po kg tjelesne težine djeteta. (pogledajte tablicu ispod za primjere doziranja).
English: What Keppra is and what it is used for What you need to know before you take Keppra How to take Keppra
Croatian: Što je Keppra i za što se koristi Što morate znati prije nego počnete uzimati Keppru
English: One maximum single dose of Keppra concentrate contains 2.5 mmol (or 57 mg) of sodium (0.8 mmol (or 19 mg) of sodium per vial).
Croatian: Jedna najveća pojedinačna doza Keppra koncentrata sadrži 2,5 mmola (ili 57 mg) natrija (0,8 mmola (ili 19 mg) natrija po bočici).
English: Infants 6 to 23 months, children and adolescents weighing less than 50 kg
Croatian: Dojenčad od 6 do 23 mjeseca, djeca i adolescenti tjelesne težine manje od 50 kg
English: What you need to know before you take Keppra
Croatian: Što morate znati prije nego počnete uzimati Keppru
English: (see table below for dose examples).
Croatian: (naveden u dijelu 6.).
English: • Dose in adults and adolescents (from 16 years of age):
Croatian: • Doza za odrasle i adolescente (od 16. godine života):
English: Keppra 100 mg/ml oral solution contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).
Croatian: Keppra 100 mg/ml oralna otopina sadrži metilparahidroksibenzoat (E218) i propilparahidroksibenzoat (E216) koji mogu izazvati alergijske reakcije (koje mogu biti i odgođene).
English: Intermediate packaging containing 100 tablets for box of 200 (2 x 100) tablets without blue box
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Srednje pakiranje koje sadrži 100 tableta za kutiju od 200 (2 x 100) tableta, bez plavog okvira
English: Film-coating:
Croatian: Otopine za razrjeđivanje:
English: The other ingredients are: sodium citrate, citric acid monohydrate, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), ammonium glycyrrhizate, glycerol (E422), maltitol liquid (E965), acesulfame potassium (E950), grape flavour, purified water.
Croatian: Pomoćne tvari su: natrijev citrat, citratna kiselina, monohidrat, metilparahidroksibenzoat (E218), propilparahidroksibenzoat (E216), amonijev glicirizat, glicerol (E422), tekući maltitol (E965), acesulfamkalij (E950), aroma grožđa, pročišćena voda.
English: Keppra oral solution also contains maltitol.
Croatian: Keppra 100 mg/ml oralna otopina također sadrži maltitol.
English: 5 ml glass vial (type I) closed by a polytetrafluoroethylene grey chlorobutyl rubber stopper or an uncoated grey bromobutyl rubber stopper and sealed with an aluminium/polypropylene flip cap. Each carton contains 10 vials.
Croatian: Staklena bočica (tip I) od 5 ml zatvorena sivim klorobutilnim gumenim čepom obloženim politetrafluoroetilenom ili s neobloženim sivim brombutilnim gumenim čepom i zapečaćena s aluminijskim/polipropilenskim „flip“ zatvaračem.
English: Preparation and administration of Keppra concentrate for solution for infusion Dose Withdrawal Volume
Croatian: Priprema i primjena Keppra koncentrata za otopinu za infuziju Doza Volumen koji se treba izvući iz bočice
English: The tablet formulation is not adapted for use in infants and children under the age of 6 years.
Croatian: Farmaceutski oblik tableta nije prilagođena za primjenu kod dojenčadi i djece mlađe od 6 godina.
English: 150 mg (1.5 ml) twice daily 450 mg (4.5 ml) twice daily
Croatian: 150 mg (1,5 ml) dva puta na dan 450 mg (4,5 ml) dva puta na dan
English: For infants 1 month to less than 6 months, measure the appropriate dosage using the 1 ml syringe included in the package.
Croatian: Za dojenčad u dobi od 1 mjeseca do manje od 6 mjeseci, odmjerite odgovarajuću dozu koristeći štrcaljku od 1 ml koja je priložena u pakiranju.
English: What Keppra is and what it is used for What you need to know before you are given Keppra How Keppra is given
Croatian: Što je Keppra i za što se koristi Što morate znati prije nego počnete dobivati Keppru
English: Dose recommendations for infants aged from 1 month to less than 6 months:
Croatian: Preporučene doze za dojenčad u dobi od 1mjeseca do manje od 6 mjeseci:
English: Three presentations are available: - A 300 ml bottle with a 10 ml oral syringe (delivering up to 1000 mg levetiracetam) graduated every 0.25 ml (corresponding to 25 mg).
Croatian: Dostupne su tri veličine pakiranja: - Boca od 300 ml sa štrcaljkom za usta od 10 ml (koja dostavlja do 1000 mg levetiracetama) s podjelama po 0,25 ml (što odgovara količini od 25 mg).
English: If you forget to take Keppra:
Croatian: Ako ste zaboravili uzeti Keppru
English: General dose: Keppra is taken twice daily, in two equally divided doses, each individual dose being measured between 0.07 ml (7mg) and 0.21 ml (21mg), per kg bodyweight of the infant.
Croatian: Uobičajena doza: Keppra se uzima dva puta na dan, u dvije jednako podijeljene doze, a svaku pojedinu dozu treba odmjeriti između 0,07 ml (7 mg) i 0,21 ml (21 mg), po kg tjelesne težine dojenčeta. (pogledajte tablicu ispod za primjere doziranja).
English: Only use the 1 ml syringe included in the package.
Croatian: Koristite samo štrcaljku od 1 ml koja se nalazi u pakiranju.
English: type Ca currents and by reducing the release of Ca from intraneuronal stores.
Croatian: N-tip protoka Ca2+ i smanjuje otpuštanje Ca2+ iz skladišta u neuronima.
English: For children 6 years and above, Keppra oral solution should be used for doses under 250 mg, for doses not multiple of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets.
Croatian: U djece od 6 godina i starije, Keppra oralnu otopinu treba primijenjivati za doze ispod 250 mg, doze koje nisu višekratnici od 250 mg, odnosno kada preporučeno doziranje ne može biti postignuto uzimanjem većeg broja tableta te u bolesnika koji ne mogu gutati tablete.
English: The possible side effects of an overdose of Keppra are sleepiness, agitation, aggression, decrease of alertness, inhibition of breathing and coma.
Croatian: Moguće su nuspojave predoziranja Kepprom pospanost, uznemirenost, agresija, smanjena pozornost, smetnje disanja i koma.
English: The other ingredients are: sodium acetate, glacial acetic acid, sodium chloride, water for injections.
Croatian: Drugi sastojci su: natrijev acetat, ledena acetatna kiselina, natrijev klorid, voda za injekcije.
English: Keppra oral solution is the preferred formulation for use in infants and children under the age of 6 years.
Croatian: Keppra oralna otopina je najprikladniji farmaceutski oblik za primjenu u dojenčadi i djece mlađe od 6 godina.
English: Box of 10 vials
Croatian: Jedna kutija sadrži 10 bočica.
English: • Separate the adaptor from the syringe (figure 2).
Croatian: • Odvojite nastavak za štrcaljku od štrcaljke (slika 2).
English: In a pooled analysis, the percentage of patients who achieved 50% or greater reduction from baseline in the partial onset seizure frequency per week at stable dose (12/14 weeks) was of 27.7 %, 31.6 % and 41.3 % for patients on 1000, 2000 or 3000 mg levetiracetam respectively and of 12.6 % for patients on placebo.
Croatian: Analizom zbirnih podataka utvrđeno je da je postotak bolesnika kod kojih je postignuto 50 %-tno ili više smanjenje od početne učestalosti parcijalnih napadaja tjedno uz konstantnu dozu (12/14 tjedana) bio 27,7% kod uzetih 1000 mg, 31,6% kod uzetih 2000 mg i 41,3% kod uzetih 3000 mg levetiracetama te 12,6% kod uzimanja placeba.
English: Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Croatian: Keppra je indicirana kao monoterapija u liječenju parcijalnih napadaja sa sekundarnom generalizacijom ili bez nje u odraslih i adolescenata od 16. godine života s novodijagnosticiranom epilepsijom.
English: Keppra contains methyl parahydroxybenzoate, propyl parahydroxybenzoate and maltitol Keppra oral solution includes methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).
Croatian: Keppra sadrži metilparahidroksibenzoat, propilparahidroksibenzoat i maltitol Keppra 100 mg/ml oralna otopina sadrži metilparahidroksibenzoat (E218) i propilparahidroksibenzoat (E216) koji mogu izazvati alergijske reakcije (koje mogu biti i odgođene).
English: Keppra contains sodium
Croatian: Keppra sadrži natrij
English: • Dextrose 50 mg/ml (5%) solution for injection
Croatian: • otopina glukoze 50 mg/ml (5 %) za injekciju
English: The 300 ml glass bottle of Keppra (for children aged 4 years and above, adolescents and adults) is packed in a cardboard box containing a 10 ml oral syringe (graduated every 0.25 ml) and an adaptor for the syringe.
Croatian: Staklena boca od 300 ml Keppre (za djecu u dobi od 4 godine i stariju, adolescente i odrasle) pakirana je u kartonsku kutiju koja još sadrži štrcaljku za usta od 10 ml (s oznakom na svakih 0,25 ml) i nastavak za štrcaljku.
English: For children 6 months to 4 years, measure the appropriate dosage using the 3 ml syringe included in the package.
Croatian: Za djecu u dobi od 6 mjeseci do 4 godine, odmjerite odgovarajuću dozu koristeći štrcaljku od 3 ml koja je priložena u pakiranju.
English: Aluminium/PVC blister
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP Aluminij/PVC blister
English: Keppra 100 mg/ml oral solution Levetiracetam
Croatian: Keppra 100 mg/ml oralna otopina levetiracetam
English: The other ingredients are: Tablet core: croscarmellose sodium, macrogol 6000, silica colloidal anhydrous, magnesium stearate.
Croatian: Jezgra tablete: umrežena karmelozanatrij, makrogol 6000, bezvodni koloidni silicijev dioksid, magnezijev stearat.
English: Excipient with known effect: Each film-coated tablet contains 0.19 mg of sunset yellow FCF (E110).
Croatian: Jedna filmom obložena tableta sadrži 0,19 mg sunset yellow FCF (E110).
English: The CLcr in ml/min/1.73 m2 may be estimated from serum creatinine (mg/dl) determination, for young adolescents and children using the following formula (Schwartz formula):
Croatian: Klirens kreatinina u ml/min/1,73 m2 može se za mlade adolescente i djecu procijeniti iz vrijednosti serumskoga kreatinina (mg/dl) s pomoću sljedeće formule (Schwartzova formula):
English: Film-coating: Polyvinyl alcohol-part. hydrolyzed, titanium dioxide (E171), macrogol 3350, talc, colourants*.
Croatian: Film ovojnica: djelomično hidroliziran polivinilni alkohol, titanijev dioksid (E171), makrogol 3350, talk, bojila*.
English: How to take Keppra
Croatian: Kako uzimati Keppru
English: Other ingredients include sodium acetate, glacial acetic acid, sodium chloride, water for injections.
Croatian: Ostale pomoćne tvari su natrijev acetat, ledena acetatna kiselina, natrijev klorid, voda za injekcije.
English: Sodium acetate Glacial acetic acid Sodium chloride Water for injections
Croatian: 6.1 Popis pomoćnih tvari natrijev acetat acetatna kiselina, ledena natrijev klorid voda za injekcije
English: EU/1/00/146/026 200 tablets (2 packs of 100) EU/1/00/146/037 100 x 1 tablets
Croatian: EU/1/00/146/026 200 tableta (2 pakiranja od 100) EU/1/00/146/037 100 x 1 tableta
English: The NOAEL was ≥ 1800 mg/kg/day for the F0 females, and for the survival, growth and development of the F1 offspring up to weaning (x 6 the MRHD on a mg/m2 basis).
Croatian: NOAEL je iznosila ≥ 1800 mg/kg/dan za F0 ženke, te za preživljenje, rast i razvoj za F1 potomstvo do odbića (6-erostruka vrijednost najveće preporučene doze za čovjeka izražena u mg/m2).
English: • asthenia/fatigue (tiredness).
Croatian: • astenija /umor (zamaranje).
English: How to store Keppra
Croatian: Kako čuvati Keppru
English: Only use the 3 ml syringe included in the package.
Croatian: Koristite samo štrcaljku od 3 ml koja se nalazi u pakiranju.
English: Contact your doctor if you took more Keppra than you should.
Croatian: Obavijestite liječnika ako ste uzeli veću količinu Keppre nego što ste trebali.
English: UCB Pharma SA Allée de la Recherche 60 B-1070 Brussels Belgium
Croatian: UCB Pharma SA Allée de la Recherche 60 B-1070 Brussels BELGIJA
English: UCB Pharma SA Allée de la Recherche 60 B-1070 Brussels BELGIUM
Croatian: UCB Pharma SA Allée de la Recherche 60 B-1070 Brussels Belgija
English: For children above 4 years, measure the appropriate dosage using the 10 ml syringe included in the package.
Croatian: Za djecu u dobi iznad 4 godine, odmjerite odgovarajuću dozu koristeći štrcaljku od 10 ml koja je priložena u pakiranju.
English: If you stop taking Keppra:
Croatian: Ako prestanete uzimati Keppru
English: Only use the 10 ml syringe included in the package.
Croatian: Koristite samo štrcaljku od 10 ml koja se nalazi u pakiranju.
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
Croatian: SADRŽAJ PO TEŽINI, VOLUMENU ILI DOZNOJ JEDINICI LIJEKA 500 mg/5 ml
English: 44.6 % of the levetiracetam treated patients and 19.6 % of the patients on placebo had a 50 % or greater reduction from baseline in the partial onset seizure frequency per week.
Croatian: U 44,6% bolesnika liječenih levetiracetamom i 19,6% bolesnika koji su dobivali placebo zapaženo je 50 %-tno ili više smanjenje od početne učestalosti parcijalnih napadaja tjedno.
English: What you need to know before you are given Keppra
Croatian: Što morate znati prije nego počnete dobivati Keppru
English: Keppra is for intravenous use.
Croatian: Keppra se daje u venu.
English: Suicide attempt, suicidal ideation, psychotic disorder, abnormal behaviour, hallucination, anger, confusional state , panic attack, affect lability/mood swings, agitation
Croatian: Pokušaj samoubojstva, suicidalne misli, psihotični poremećaj, poremećaj ponašanja, halucinacije, srditost, konfuzno stanje, napadaj panike, labilnost afekta/promjene raspoloženja, agitacija
English: EU/1/00/146/028 200 tablets (2 packs of 100) EU/1/00/146/036 100 x 1 tablets
Croatian: EU/1/00/146/028 200 tableta (2 pakiranja od 100) EU/1/00/146/036 100 x 1 tableta
English: • skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (StevensJohnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis);
Croatian: jako rasprostranjen osip s mjehurma i kožom koja se ljušti, osobito oko usta, nosa, očiju i genitalija (Stevens-Johnsonov sindrom), i mnogo teži oblik koji uzrokuje ljuštenje kože na više od 30% površine tijela (toksična epidermalna nekroliza);
English: Keppra 100 mg/ml concentrate for solution for infusion Levetiracetam
Croatian: Keppra 100 mg/ml koncentrat za otopinu za infuziju levetiracetam
English: Keppra 100 mg/ml concentrate for solution for infusion
Croatian: NAZIV LIJEKA Keppra 100 mg/ml koncentrat za otopinu za infuziju
English: - A 150 ml bottle with a 3 ml oral syringe (delivering up to 300 mg levetiracetam) graduated every 0.1 ml (corresponding to 10 mg)
Croatian: - Boca od 150 ml sa štrcaljkom za usta od 3 ml (koja dostavlja do 300 mg levetiracetama) s podjelama po 0,1 ml (što odgovara količini od 10 mg).
English: EU/1/00/146/030 (polytetrafluoroethylene -faced stopper) EU/1/00/146/033 (Uncoated stopper)
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/00/146/030 (čep obložen politetrafluoroetilenom) EU/1/00/146/033 (neobložen čep)
English: - A 150 ml bottle with a 1 ml oral syringe (delivering up to 100 mg levetiracetam) graduated every 0.05 ml (corresponding to 5 mg)
Croatian: - Boca od 150 ml sa štrcaljkom za usta od 1 ml (koja dostavlja do 100 mg levetiracetama) s podjelama po 0,05 ml (što odgovara količini od 5 mg).
English: One tablet of Keppra 1,000 mg contains 1,000 mg of levetiracetam.
Croatian: Jedna tableta Keppre 1000 mg sadrži 1000 mg levetiracetama.
English: The 150 ml glass bottle of Keppra (for infants aged 1 month to less than 6 months) is packed in a cardboard box containing a 1 ml oral syringe (graduated every 0.05 ml) and an adaptor for the syringe.
Croatian: Staklena boca od 150 ml Keppre (za dojenčad u dobi od 1 mjeseca do manje od 6 mjeseci) pakirana je u kartonsku kutiju koja još sadrži štrcaljku za usta od 1 ml (s oznakom na svakih 0,05 ml) i nastavak za štrcaljku.
English: Depression, hostility/ aggression, anxiety, insomnia, nervousness/ irritability
Croatian: Depresija, netrpeljivost/ agresivnost, anksioznost, nesanica, nervoza/razdražljivost
English: EU/1/00/146/001 20 tablets EU/1/00/146/002 30 tablets EU/1/00/146/003 50 tablets EU/1/00/146/004 60 tablets EU/1/00/146/005 100 tablets EU/1/00/146/029 200 tablets (2 packs of 100) EU/1/00/146/034 100 x 1 tablets
Croatian: EU/1/00/146/001 20 tableta EU/1/00/146/002 30 tableta EU/1/00/146/003 50 tableta EU/1/00/146/004 60 tableta EU/1/00/146/005 100 tableta EU/1/00/146/029 200 tableta (2 pakiranja od 100) EU/1/00/146/034 100 x 1 tableta
English: 500 mg/5 ml
Croatian: OBLIK I SADRŽAJ 500 mg/5 ml